Ensuring that all paediatricians and rheumatologists recognise significant rheumatic diseases

Helen Foster1, Yukiko Kimura

  • 1Newcastle University, Medical School, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK. h.e.foster@ncl.ac.uk

Insights

Generalist clinicians often see children with musculoskeletal (MSK) issues but lack specialized training. Improving their education is crucial for early detection of rheumatic diseases in pediatric patients.

Area of Science:

  • Pediatric Rheumatology
  • Musculoskeletal Medicine
  • General Practice

Background:

  • Generalists are the primary point of contact for children with musculoskeletal (MSK) problems.
  • Many generalists lack specialized training in pediatric musculoskeletal (pMSK) medicine.
  • Early recognition of rheumatic diseases in children is critical for timely intervention.

Purpose of the Study:

  • To highlight the need for improved education for generalists in pediatric rheumatology.
  • To emphasize the importance of recognizing significant rheumatic diseases in children.
  • To provide a basis for developing better training strategies for generalist clinicians.

Main Methods:

  • This article reviews current educational deficiencies in pMSK medicine for generalists.
  • It identifies key areas where generalists encounter children with MSK conditions.
  • The focus is on the diagnostic challenges faced by non-specialists.

Main Results:

  • Generalist clinicians frequently encounter pediatric MSK cases.
  • Existing education and training inadequately prepare generalists to identify serious rheumatic conditions.
  • There is a significant gap in the ability of generalists to manage or appropriately refer pediatric rheumatic diseases.

Conclusions:

  • Enhanced education and training are urgently needed for generalists in pediatric rheumatology.
  • Improving generalist recognition of pediatric rheumatic diseases will improve patient outcomes.
  • Addressing educational deficits is essential for effective healthcare delivery in pediatric MSK medicine.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...